With over thirty years experience in pharma Tapan Ray has a broad overview of how Indian pharma currently ... It is good for the country that 100% FDI in the pharmaceutical sector has remained ...

The government revised Schedule M under the Drugs & Cosmetic Act in 2023 to make it mandatory for companies to follow Good ...

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces for U.S. President Donald Trump's plans to tax pharmaceutical imports.

Indian pharmaceutical companies will be able to retain their dominant market share in the US in selling generic drugs even if President Donald Trump imposes high tariffs because they are “highly ...

Indian pharma CDMOs remain resilient, continuing to thrive due to favorable global factors. The B&K Securities report ...

Indian pharmaceutical companies are aggressively expanding their US presence through a wave of acquisitions, likely as a hedge against future uncertainties. Leading players like Sun Pharma ...

The Indian Pharmaceutical Alliance (IPA) will host the 10th Global Pharmaceutical Quality Summit (GPQS) on February 27-28, 2025, at the J.W. Marriott Juhu in Mumbai. With the theme "Navigating the ...